Target intelligence / Profile preview

BEAN1 antisense RNA 1 (BEAN1-AS1)

Target
BEAN1-AS1
Molecular classification
Long non-coding RNA (lncRNA), Antisense RNA, Non-coding RNA (ncRNA)
01

Overview

BEAN1 antisense RNA 1 (BEAN1-AS1) is a long non-coding RNA gene found in the human genome, transcribed in an antisense orientation relative to the BEAN1 protein-coding gene[1][3][4]. It is classified as a non-coding RNA, meaning its transcript is not translated into a protein, but may play a role in regulating the expression of its sense gene (BEAN1), for example by modulating transcription or RNA stability in a *cis*-acting manner as is typical for many antisense lncRNAs[4][7][9]. It is annotated in databases such as GeneCards and Ensembl under the accession numbers ENSG00000261656 (Ensembl) and 101927726 (NCBI Gene)[1][3][4][6]. There are currently no known drugs, direct disease links, or validated biomarker or safety data for BEAN1-AS1. Its aliases include "CTD-2258A20.5"[1][3]. Notes: - This is an *RNA gene* and *not* a classical therapeutic target such as a receptor, enzyme, or transporter. - Function and disease associations may become clearer in the future as more functional studies are published, but there is currently no direct experimental evidence for specific biological functions or disease roles of BEAN1-AS1[3][4][6]. - General properties are inferred from the class of long non-coding antisense RNAs, which often function in gene expression regulation and epigenetic modification[7][9].

Other names
CTD-2258A20.5
02

Biological functions

Regulation of gene expressionEpigenetic regulation (inferred for antisense RNAs generally)Modulation of neighboring gene (cis-acting lncRNA activity)
03

Disease associations

Other (there is no evidence in major public databases directly linking BEAN1-AS1 to well-established disease pathologies such as cancer or neurodegeneration as of current knowledge)

Beyond the preview

Go deeper on BEAN1 antisense RNA 1 (BEAN1-AS1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on BEAN1 antisense RNA 1 (BEAN1-AS1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call